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Both glial cell line-derived neurotrophic factor (GDNF) and fibroblast growth factor 2 (FGF2) are bona fide self-renewal factors for sper-
matogonial stem cells, whereas retinoic acid (RA) induces spermatogonial differentiation. In this study, we investigated the functional
differences between FGF2 and GDNF in the germline niche by providing these factors using a drug delivery system in vivo. Although
both factors expanded the GFRA1+ subset of undifferentiated spermatogonia, the FGF2-expanded subset expressed RARG, which is indis-
pensable for proper differentiation, 1.9-fold more frequently than the GDNF-expanded subset, demonstrating that FGF2 expands a dif-
ferentiation-prone subset in the testis. Moreover, FGF2 acted on the germline niche to suppress RA metabolism and GDNF production,
suggesting that FGF2modifies germline niche functions to bemore appropriate for spermatogonial differentiation. These results suggest
that FGF2 contributes to induction of differentiation rather than maintenance of undifferentiated spermatogonia, indicating reconsid-
eration of the role of FGF2 in the germline niche.
INTRODUCTION
Spermatogonial stem cells (SSCs) are a subpopulation of
undifferentiated spermatogonia and the origin of sper-
matogenesis. They reside in a specialized microenviron-
ment called the germline niche located at the periphery
of seminiferous tubules inmammalian testes. The germline
niche permits SSCs to produce both stem cells and
committed progenitors called differentiating spermato-
gonia by repeated self-renewal and differentiation. Differ-
entiating spermatogonia further amplify their population
by several mitotic divisions and enter meiotic division to
produce spermatozoa (de Rooij and Russell, 2000).
It is well established that glial cell line-derived neurotro-
phic factor (GDNF) ensures the survival and self-renewal
of SSCs. Meng et al. (2000) demonstrated that GDNF
is indispensable for SSC self-renewal by analyzing
Gdnf transgenic/deficient mice. Kanatsu-Shinohara et al.
(2003) took advantage of GDNF functions to establish
cultured SSCs termed germline stem (GS) cells from
mouse pup testes. This technique enables identification
of cytokines and chemicals that affect the behavior of
SSCs.
Our recent study revealed that fibroblast growth factor 2
(FGF2) is another bona fide self-renewal factor for SSCs
(Takashima et al., 2015). FGF2-cultured spermatogonia
(F-SPG) cultured for more than 4 months under GDNF-
free conditions colonized infertile mouse testes and
restored fertility by spermatogonial transplantation.
Compared with GDNF-cultured spermatogonia (G-SPG),
F-SPG exhibit more differentiated characteristics such as
lower SSC activity and higher KIT expression in addition
to a difference in MAP2K1/2 dependency. These data sug-
gest that FGF2 plays a distinct role in regulating undifferen-
tiated spermatogonia in vivo.
It is also known that retinoic acid (RA) is required
for spermatogonial differentiation (Hogarth et al., 2011).
Of three RA receptor isotypes, retinoic acid receptor g
(RARG) has been reported to specifically contribute to
this process (Gely-Pernot et al., 2012). Recently, Ikami
et al. (2015) demonstrated that RARG expression is suffi-
cient for induction of RA susceptibility in undifferentiated
spermatogonia expressing GFRA1 that triggers GDNF
signaling in combination with transmembrane receptor
tyrosine kinase RET (Sariola and Saarma, 2003). For further
understanding, it should be elucidated how RARG+
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spermatogonia are derived from GFRA1+ undifferentiated
spermatogonia and how RA signals are regulated within
the germline niche.
Although FGF2 is considered to be a possible candidate
that induces theRARG+ subsetofundifferentiated spermato-
gonia, the absence of an animal model has hampered the
analysis. Fgf2-transgenic mice are fertile and not reported
to have abnormal testes (Coffin et al., 1995). This is because
transgenicmicemightnot showextremely strong transgene
expression depending on the gene. Furthermore, FGF2-
knockout mice show no obvious defects in testicular func-
tions (Zhouet al., 1998),whichmaybebecauseof functional
complementation by other FGF molecules.
To overcome such circumstances, we used the biode-
gradable gelatin microsphere (BGM) system to provide
strong FGF2 stimuli only in the testis. This system was es-
tablished and reported primarily by Tabata et al. (1999).
BGMs were prepared by glutaraldehyde-mediated cross-
linking of acidic gelatin (microsphere diameter: 30–
100 mm). FGF2 can be adsorbed onto BGMs and released
depending on the biodegradation of BGMs (Yamamoto
et al., 2001). BGMs were first applied to deliver FGF2 into
the skin to induce neovascularization (Tabata et al.,
1999) and later applied to deliver bone morphogenetic
protein 2 and transforming growth factor b1 for heart
and bone regeneration (Ueda et al., 2002; Yamamoto
et al., 2006; Marui et al., 2007). Uchida et al. (2016) also
employed a similar system using different material to
induce hyperproliferation of undifferentiated spermato-
gonia by GDNF treatment, as observed in the previous
report of Meng et al. (2000). These reports encouraged
employment of the BGM system.
In this study,weanalyzed themolecular functionsof FGF2
in the mouse germline niche using BGMs for direct FGF2
stimulation in vivo. Althoughwe found that FGF2 expanded
GFRA1+ spermatogonia, these cells exhibited a phenotype
distinct from that of GDNF-expanded GFRA1+ spermato-
gonia. Moreover, FGF2 modified germline niche functions
to be more appropriate for spermatogonial differentiation.
RESULTS
Fgf2 Expression in the Testis
To identify the origin of FGF2 in the testis, we conducted
qRT-PCR analyses. For Sertoli cell analysis, we used R26-
CAG-LoxP-hCD271; Amh-Cre mice to purify Sertoli cells
by magnetic-activated cell sorting (MACS) (Figure S1A)
(Kuroki et al., 2015). Although purified Sertoli cells
expressed Gdnf, Fgf2 expression was very low compared
with whole testis cells, suggesting that other cell types
express Fgf2 (Figures S1B and S1C). In contrast, germ cell
depletion decreased Fgf2 expression to some extent, sug-
gesting that germ cells and other components of the
germline niche express Fgf2 (Figures S1D and S1E). We
also detected FGF2 in the testes of rodents, domestic
animals, and humans, suggesting conservation of FGF2
production in mammalian testes (Figure S1F).
FGF2 Expands GFRA1+ Spermatogonia In Vivo
Weexamined the functions of FGF2 in the testis by applying
BGMs for continual growth factor stimulation in vivo (Fig-
ure 1A) (Tabata et al., 1999). Growth factor-adsorbed BGMs
were transplanted directly into the testicular interstitium
ofC57BL6/Nmice (7weeksold)under isofluraneanesthesia.
Until sacrifice,bromodeoxyuridine (BrdU)was administered
via water ad libitum to label proliferating cells. At 10 days
after the procedure, BGM-treated testes were harvested and
examined by immunofluorescence staining (Figure 1B).
Although six testes were included in each group (mock-,
FGF2-, and GDNF-BGMs), five testes (mock-BGM), six testes
(FGF2-BGM), and four testes (GDNF-BGM)were successfully
Figure 1. FGF2 Expands GFRA1+ Spermatogonia Phenotypically Distinct from Those Induced by GDNF
(A) Flow chart of biodegradable gelatin microsphere (BGM) experiments. Mock-, FGF2-, or GDNF-adsorbed BGMs were bilaterally injected
into the interstitium of 7-week-old mouse testes. BrdU was administered via water ad libitum until mice were sacrificed. At 10 days after
injection, testes were analyzed by immunofluorescence staining. Results were obtained independently from three mice.
(B and C) Cluster formation and proliferation of GFRA1+ spermatogonia induced by BGM transplantation. (B) Immunofluorescence staining.
GFRA1 and incorporated BrdU are visualized by cyan and red, respectively. Nuclei were counterstained with Hoechst 33,342 (gray).
(C) Classification of large GFRA1+ clusters by the number of constituting spermatogonia. Mock-BGMs, n = 5 testes; FGF2-BGMs, n = 6 testes;
GDNF-BGMs, n = 4 testes. A total of 1,434 tubules with 261 large GFRA1+ clusters carrying 2749 GFRA1+ spermatogonia were analyzed.
(D–G) Characterization of BGM-induced large GFRA1+ clusters. (D and E) PLZF expression in large GFRA1+ clusters. (D) Immunofluorescence
staining. GFRA1 is visualized by cyan, while PLZF is visualized by green. Nuclei were counterstained with Hoechst 33,342 (gray).
(E) Quantitative analysis of PLZF expression in large GFRA1+ clusters. FGF2-BGMs, n = 5 testes; GDNF-BGMs, n = 4 testes. A total of
957 tubules with 190 large GFRA1+ clusters carrying 2,111 GFRA1+ spermatogonia were analyzed. In this experiment, one FGF2-BGM-
treated testis, which did not carry large GFRA1+ clusters, was excluded from the statistical analysis. (F and G) RARG expression in large
GFRA1+ clusters. (F) Immunofluorescence staining. GFRA1 is visualized by cyan, while RARG is visualized by red. Nuclei were counter-
stained with Hoechst 33,342 (gray). (G) Quantitative analysis of RARG expression in large GFRA1+ clusters. FGF2-BGMs, n = 6 testes; GDNF-
BGMs, n = 4 testes. A total of 1,347 tubules with 214 large GFRA1+ clusters carrying 2,147 GFRA1+ spermatogonia were analyzed.
Results are presented as means ± SEM. Scale bars, 50 mm (B, D, and F). See also Figures S1 and S2; Table S1.
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transplanted with BGMs. Testes were harvested indepen-
dently from three mice for each group.
In adult mice, most GFRA1+ spermatogonia exist as sin-
gle or paired cells, and spermatogonial clusters consisting
of three ormore cells are rare (Suzuki et al., 2009; Nakagawa
et al., 2010; Grasso et al., 2012). In agreement with these
previous studies, transplantation ofmock-BGMs had no ef-
fect on GFRA1+ spermatogonia. Most GFRA1+ spermato-
gonia were found as single or paired cells (Figure 1B).
Next, we defined GFRA1+ spermatogonial clusters consist-
ing of three or more cells as ‘‘large GFRA1+ clusters.’’ In
this regard, we also classified large GFRA1+ clusters into
five classes based on the number of constituting GFRA1+
spermatogonia (Figures 1C and S2A). We found only 17
large GFRA1+ clusters consisting of three or four spermato-
gonia in 507 tubule sections from five testes (Figure 1C).
GDNF-BGMs often induced large GFRA1+ clusters
exhibiting a multi-layered, dome-like morphology (Fig-
ures 1B, S2A, and S2B). This result is consistent with a
previous report showing that intratesticular transplanta-
tion of GDNF-soaked beads induces hyperproliferation of
GFRA1+ spermatogonia (Uchida et al., 2016). A total of
185 large GFRA1+ clusters were found in 457 tubule sec-
tions from four testes, and 82.7% (153/185) of clusters
consisted of more than four spermatogonia (Figure 1C).
Although FGF2-BGMs also induced large GFRA1+ clusters,
these cells were prone to form two-dimensional flat col-
onies along the basement membrane of seminiferous tu-
bules (Figures 1B and S2A–S2D). Fifty-nine large GFRA1+
clusters were found in 470 tubule sections from six testes,
and 30.5% (18/59) of them consisted of more than four
spermatogonia (Figure 1C). In the most extreme case,
GFRA1+ spermatogonia covered the entire circumference
of the seminiferous tubule (Figure S2D). In GDNF- and
FGF2-BGM-treated testes, large GFRA1+ clusters were prone
to reside adjacent to BGMs (Figures S2B–S2D). We also
observed that GFRA1+ spermatogonia that formed large
clusters frequently incorporated BrdU (Figure 1B). These
data strongly suggest that FGF2 also acts as growth factor
for GFRA1+ spermatogonia.
Phenotypic Differences between FGF2- and GDNF-
Expanded GFRA1+ Spermatogonia
We also found morphological differences between FGF2-
and GDNF-expanded large GFRA1+ clusters, suggesting
functional differences of these factors. Therefore, we
compared the phenotypes of FGF2- and GDNF-expanded
GFRA1+ spermatogonia that formed large clusters. We
found some large GFRA1+ clusters in mock-BGM-treated
testes. However, consistent with previous reports (Suzuki
et al., 2009; Nakagawa et al., 2010), the number of large
GFRA1+ clusters was inadequate for statistical analysis.
Therefore, mock-BGM samples were omitted, and compar-
isons of FGF2-BGM and GDNF-BGM samples were con-
ducted. In this experiment, we examined expression of
two spermatogonial markers, promyelocytic leukemia
zinc finger (PLZF) protein (marker for undifferentiated sper-
matogonia) and RARG (marker for a subset of undifferenti-
ated spermatogonia and differentiating spermatogonia).
The former is expressed in a broad range of undifferentiated
spermatogonia and is essential for their maintenance
(Buaas et al., 2004; Costoya et al., 2004). The latter can
monitor the differentiation of GFRA1+ undifferentiated
spermatogonia into differentiating spermatogonia and is
necessary and sufficient for acquisition of RA signals for
differentiation into differentiating spermatogonia (Gely-
Pernot et al., 2012; Ikami et al., 2015). Ikami et al. (2015)
demonstrated that genetically modified GFRA1+ spermato-
gonia expressing RARG are persistently competent for
RA-mediated spermatogonial differentiation. Therefore,
RARG/Rarg is considered to be an appropriate marker to
monitor the differentiation of GFRA1+ spermatogonia.
Immunofluorescence staining revealed that both popula-
tions exhibited the PLZF+ phenotype typical for undiffer-
entiated spermatogonia (Figures 1D and 1E). However, a
greater percentage of FGF2-expanded GFRA1+ spermato-
gonia expressed RARG than cells expanded with GDNF
(Figures 1F and 1G). In this regard, Ikami et al. (2015)
also identified the ‘‘GFRA1+RARG+ subset’’ of undiffer-
entiated spermatogonia as an intermediate between the
GFRA1+ primitive subset and more differentiated Neurog3-
EGFP+ (RARG/Rarg) subset. Considering that RARG is
indispensable for proper spermatogonial differentiation
(Gely-Pernot et al., 2012), FGF2 might expand a differenti-
ating subset of GFRA1+ spermatogonia.
FGF2 Is Functionally More Permissive for Rarg
Expression
Next, we examined how the GFRA1+RARG+ subset was
expanded. Undifferentiated spermatogonia can be divided
into GFRA1+ and GFRA1 subsets (Garbuzov et al., 2018).
The GFRA1+ subset possesses a higher SSC frequency and
a more immature phenotype than the GFRA1 subset,
and the GFRA1 subset can produce the GFRA1+ subset
(Figure 2A). Hara et al. (2014) also observed a similar
phenomenon whereby the GFRA1+ subset produces a
Neurog3-EGFP+ subset and the latter can produce the
former. Based on these contexts, we hypothesized
three possible mechanisms that expand the GFRA1+
RARG+ subset: (1) FGF2 induces RARG expression in
the GFRA1+RARG subset; (2) FGF2 expands the GFRA1+
RARG+ subset within the GFRA1+ undifferentiated
spermatogonial population; and (3) FGF2 induces reversion
of GFRA1-undifferentiated spermatogonia into the
GFRA1+RARG+ subset. To test the former two hypotheses,
we employed SSC cell lines, GS cells, F-SPG, and G-SPG.
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These cells are powerful tools for biochemical andmolecular
analyses of undifferentiated spermatogonia (Kanatsu-Shino-
hara et al., 2003; Takashima et al., 2015). GS cells were estab-
lished and maintained consistently with both GDNF and
FGF2, while F-SPG and G-SPG were established and main-
tained consistently with FGF2 or GDNF, respectively.
Considering the persistent expression of GFRA1 in culture,
these cells recapitulated the characteristics of the GFRA+
subset of undifferentiated spermatogonia (Figure 2A).
First, we cultured GS cells on laminin-coated dishes with
or without the two growth factors and found that growth
factor stimulation suppressed Rarg in GS cells (Figures S3A
and S3B). Next, we determined which factor suppressed
Rarg in GS cells. After deprivation of growth factors for
2 days, GS cells were cultured for another 2 days with
FGF2 and/or GDNF at various concentrations. This experi-
ment revealed that both factors had a Rarg-suppressive
activity, and the concentration or combination of the
two factors did not show any change in suppression of
Rarg (Figures S3C and S3D). However, GS cells cultured
under GDNF-free conditions for 3 days (orange column)
expressed higher levels of Rarg than those cultured under
FGF2-free (blue column) or FGF2 + GDNF (purple column)
conditions (Figures 2B and 2C). Considering that F-SPG ex-
pressed a higher level of Rarg than GS cells and G-SPG (Fig-
ure 2D), it is likely that FGF2 ismore permissive thanGDNF
for expression of Rarg/RARG in GFRA1+ spermatogonia.
FGF2 Acts on the Germline Niche to Suppress GDNF
and Permits RA Actions
We also determined FGF2 functions in the germline niche.
In this experiment, we used the testes of busulfan-treated
mice, because Fgf2 expression is attenuated and the
germline niche remains functional. However, we did not
examine GDNF functions because GFRA1 is expressed
exclusively in undifferentiated spermatogonia of mouse
testes (Figures S2A–S2D). Mock- or FGF2-BGMs were trans-
planted into testes of busulfan-treated mice, and the testes
were harvested at 1 or 10 days after transplantation. Gene
expression related to germline niche functionswas assessed
by qRT-PCR and western blotting (Figure 3A).
Although we analyzed BGM-transplanted testes har-
vested at 10 days after the procedure, almost all injected
FGF2 had disappeared (Figure S4A). This result was
different from a study indicating that BGMs continue to
release FGF2 in vivo for up to 14 days after the procedure
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Figure 2. FGF2 Is Permissive for Rarg Expression in Cultured
Spermatogonial Cell Lines
(A) Schematic representation of the phenotype of spermatogonial
subsets and SSC cell lines based on previous reports (Gely-Pernot
et al., 2012; Hara et al., 2014; Ikami et al., 2015; Takashima et al.,
2015; Garbuzov et al., 2018).
(B and C) Effects of FGF2 and GDNF on Rarg expression in GS cells.
(B) GS cell culture conditions. Cells were cultured on laminin-
coated dishes. (C) qRT-PCR analysis. After normalization to Hprt
expression, values of FGF2 + GDNF were set to 1.0 (n = 8 inde-
pendent cultures for each group).
(D) qRT-PCR analysis of Rarg expression in cultured spermatogonial
cell lines. After normalization to Hprt expression, the value of GS
cells was set to 1.0 (GS cells, n = 13 independent cultures; F-SPG,
n = 14 independent cultures; G-SPG, n = 18 independent cultures).
Results were obtained from three (GS cells and F-SPG) and four (G-
SPG) independently established sublines for each group.
Results are presented as means ± SEM. Daggers indicate statistical
significance (yp < 0.05).
See also Figure S3 and Table S2.
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related to germline niche functions was unchanged (Fig-
ure S4B). However, this BGM system was supposed to be
adequate to assess the molecular functions of FGF2 in
the germline niche, because this procedure succeeded in
inducing hyperproliferation of GFRA1+ spermatogonia by
GDNF/FGF2 (Figures 1B, 1C, and S2A–S2D). In contrast,
testes harvested at 1 day after the procedure still retained
a substantial and non-physiological amount of FGF2, and
Gdnf/GDNF was downregulated (Figures 3B and 3C). These
results are consistentwith our previous report showing that
Fgf2 knockdown inmouse testes induces GDNF production
(Takashima et al., 2015). Moreover, we found suppression
of Cyp26b1 that encodes an RA-metabolizing enzyme (Fig-
ure 3C). Although the role ofCyp26c1 inmice remains to be
elucidated, considering that deficiency ofCyp26b1, but not
Cyp26a1, in Sertoli cells compromises spermatogenesis
(Hogarth et al., 2015a), it has been suggested that FGF2
plays an important role in regulating RA metabolism in
the germline niche by regulating Cyp26b1. To further un-
derstand the regulation of Gdnf and Cyp26 genes, we
assessed RA functions in the germline niche. In this exper-
iment, busulfan-treated mice were intraperitoneally in-
jected with 750 mg of RA and their testes were harvested
at 11 hr after treatment. qRT-PCR analysis revealed that
Cyp26a1 and Cyp26c1 were induced by RA while Cyp26b1
was unaffected, suggesting that Cyp26b1 is specifically
regulated by FGF2 in the germline niche (Figure S4C). RA
injection also suppressed Gdnf, which is consistent with a
previous study (Hasegawa et al., 2013). Taken together,






(44 mg/kg body weight)
at 3-week-old
Interstitial injection of FGF2-adsorbed
biodegradable gelatin microspheres (BGMs)
at 7-week-old
 FGF2 diffusion 
in germline niche

































































1 2 3 4 5 6 21 22 23 24 25 26 27 28 29 30
Mock-BGMs FGF2-BGMs Mock-BGMs FGF2-BGMs





































Figure 3. FGF2 Acts on the Germline Niche to Suppress Gdnf/GDNF and Cyp26b1
(A) Flow chart of the BGM experiment to assess FGF2 functions in the germline niche. Busulfan-treated testes, in which germ cells are
depleted and germline niches remain functional, were used in this analysis. At 1 or 10 days after BGM transplantation, testes were
harvested and analyzed by qRT-PCR and western blotting.
(B) Western blot analyses of testes at 1 day after BGM treatment. Band intensities of the Mock-BGM group were set to 1.0 (n = 8 testes for
each condition).
(C) qRT-PCR analysis of testes at 1 day after BGM treatment. After normalization to Hprt expression, values of the Mock-BGM group were set
to 1.0 (n = 8 testes for each condition).
Results are presented as means ± SEM. See also Figure S4; Tables S1 and S2.
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functions to bemore appropriate for spermatogonial differ-
entiation by suppressing GDNF and RA metabolism.
DISCUSSION
We investigated the functions of FGF2 in the germline
niche. Although FGF2 expanded GFRA1+ spermatogonia
in vivo, these cells exhibited a more differentiated pheno-
type (RARG expression) than those expanded by GDNF.
Moreover, FGF2 suppressed RAmetabolism and GDNF pro-
duction. These results suggest that FGF2 acts on both
GFRA1+ spermatogonia and their niche to facilitate sper-
matogonial differentiation, despite the fact that FGF2 is a
bona fide self-renewal factor for SSCs.
We applied BGMs for sustained stimulation by growth
factors in vivo. Although our previous report employed
lentivirus-mediated Fgf2 overexpression in testes (Taka-
shima et al., 2015), it was difficult to judge whether it was
sufficient for functional analysis. In contrast, Uchida
et al. (2016) demonstrated that transplantation of GDNF-
soaked beads induces expansion of GFRA1+ spermato-
gonia. This observation led us to apply this procedure using
BGMs.
BGMperformance in vivo has already been demonstrated
in several studies. In mouse dermal tissue, BGMs achieved
prolonged FGF2 release for 14 days and induced angiogen-
esis, while 80% of FGF2 disappeared from the site of injec-
tion within 24 hr, and angiogenesis was not induced
without using BGMs (Yamamoto et al., 2001). Based on
these observations, we applied this system to achieve
prolonged FGF2 stimuli in the testis. Although our data
demonstrated that most of the injected FGF2 was
consumed by 10 days after the procedure, a substantial
amount of FGF2 remained at 1 day after the procedure.
Even though this system might not perform as intended
(expected stimuli for about 2 weeks), FGF2 stimulation
induced hyperproliferation of GFRA1+ undifferentiated
spermatogonia and modulated gene expression in the
germline niche. Considering that release kinetics are
different depending on the growth factor (Yamamoto
et al., 2001), it is anticipated that the release kinetics of
GDNF are also different from those of FGF2. Hence, it is
not appropriate to determine which factor is superior to
induce spermatogonial growth using the BGM system.
Using BGMs, although we found that FGF2 expanded
GFRA1+ spermatogonia, their number and size were less
than those of GDNF-expanded GFRA1+ spermatogonia.
This result might be biased by two technical reasons. One
might be undefined release kinetics of factors from BGMs
as described above. Another is the choice of analytical
method for large GFRA1+ clusters. Although we applied
whole-mount immunofluorescence to analyze testicular
tubules, synechia between seminiferous tubules and
BGMs hampered analysis of colonies formed beneath
BGMs. Simple observation of frozen sections could not
render the whole architecture of colonies. The axis of a tu-
bule section might affect the result of the size and number
of large GFRA1+ clusters. However, we succeeded in obtain-
ing colony images without collapsing their structure.
Therefore, our data regarding the number and size of large
GFRA1+ clusters might be underestimated. Based on these
circumstances, our study was limited to comparison of
the characteristics of resultant colonies induced by FGF2
or GDNF.
Both FGF2 and GDNF induced morphologically distinct
large GFRA1+ clusters in vivo. GDNF-BGMs induced
multilayered clusters that were morphologically similar to
G-SPG, whereas FGF2-BGMs induced flat colonies on the
basement membrane of seminiferous tubules, which were
similar to F-SPG (Takashima et al., 2015). Our recent report
revealed that F-SPG have a more differentiated phenotype
without losing their SSC properties. These findings suggest
that FGF2-expanded GFRA1+RARG+ spermatogonia in vivo
might have a more differentiated phenotype. Indeed,
Ikami et al. (2015) demonstrated the existence of GFRA+
RARG+ spermatogonia, and that these cells are more
susceptible than GFRA1+RARG spermatogonia to RA-
induced differentiation toward KIT+ differentiating sper-
matogonia. These observations support our speculation
that FGF2 might facilitate spermatogonial differentiation
by expanding differentiation-prone GFRA1+RARG+ sper-
matogonia (Figures 4A and 4B).
An important remaining issue is how FGF2 expands the
GFRA1+RARG+ subset of undifferentiated spermatogonia.
We determined whether FGF2 induced Rarg expression in
GFRA1+ spermatogonia using cultured spermatogonial
cell lines. In contrast to our expectation, although FGF2
suppressed Rarg in GS cells, FGF2 was relatively more
permissive for Rarg expression than GDNF. These data
strongly suggest that FGF2 does not induce Rarg in
GFRA1+ spermatogonia in vivo, rejecting the hypothesis
that FGF2 induces Rarg expression in GFRA1+ spermato-
gonia. Considering that FGF2 induces proliferation of un-
differentiated spermatogonia, it is considered that at least
some GFRA1+RARG+ spermatogonia are expanded by the
proliferation of GFRA1+RARG+ spermatogonia themselves.
Validation of the third hypothesis, that the GFRA1+RARG+
subset is derived from the GFRA1 subset via FGF2 stimuli,
still remains to be clarified. Although how FGF2 suppresses
GDNF in the germline niche (directly or through the
CYP26B1-RA pathway) remains unknown, FGF2-mediated
GDNF suppression might also contribute to expanding the
GFRA1+RARG+ subset.
Which cells produce FGF2 in the testis has been contro-
versial. Some reports demonstrated that Sertoli cells
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produce FGF2 (Smith et al., 1989; Mullaney and Skinner,
1992; Tadokoro et al., 2002), whereas others showed that
germ cells produce FGF2 (Han et al., 1993; Zhang et al.,
2012). Our results demonstrated that Sertoli cells are not
themain origin of FGF2, at least under physiological condi-
tions. Subsequent experiments revealed that germ cell
depletion attenuated Fgf2 expression in the testis. Consid-
ering that germ cell-free Nanos3-knockout mice also show
decreased Fgf8 expression in the testis (Hasegawa and
Saga, 2014), Fgf8 and Fgf2 might be expressed in a similar
manner. There are three possible explanations for this
outcome. (1) Germ cells express Fgf2, and germ cell deple-
tion causes loss of Fgf2. (2) The germline niche expresses
Fgf2 depending on the germ cell-derived signal (JAG1-
NOTCH2 pathway) (Garcia et al., 2014), and germ cell
depletion attenuates Fgf2 expressed in the germline niche.
(3) Busulfan treatment suppresses Fgf2 in the germline
niche. Direct analysis of purified testis component cells is
more likely to identify the Fgf2-expressing cells. However,
busulfan-mediated expression changes of Fgf2 and Gdnf
might be important in understanding the niche function.













































Figure 4. Putative Role of FGF2 in the
Mouse Germline Niche
(A) Molecular functions of FGF2 in the
germline niche. GDNF expands GFRA1+
RARG spermatogonia, whereas FGF2 ex-
pands GFRA1+RARG+ spermatogonia that are
a differentiation-prone subset (Ikami et al.,
2015). Simultaneously, FGF2 also acts on
the germline niche to facilitate RA actions
via Cyp26b1 suppression. GDNF suppres-
sion might also contribute to expanding
GFRA1+RARG+ spermatogonia.
(B and C) The FGF2-dominant niche is prone
to differentiation because of permissiveness
for expansion of GFRA1+RARG+ spermato-
gonia and RA actions (B), whereas the
GDNF-dominant niche is prone to regener-
ation (C). Indeed, transplanted undifferen-
tiated spermatogonia are prone to prolifer-
ation rather than differentiation in germ
cell-depleted testes (Nagano et al., 1999;
Nagai et al., 2012; Zohni et al., 2012).
The present study also demonstrated
that busulfan-mediated germ cell depletion
increased the Gdnf/Fgf2 ratio in the testis
(Figure S1).
See also Figure S1.
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modify the functions of the germline niche from a physio-
logical niche to a Gdnf-dominant niche appropriate for
regeneration (Figures 4A–4C).
We also found that FGF2, but not RA, regulated Cyp26b1
in the germline niche. Hogarth et al. (2015a) demonstrated
that Sertoli cell-expressed Cyp26b1 is indispensable for
proper spermatogenesis, whereas Cyp26a1 deficiency in
Sertoli cells does not cause any spermatogenic defects.
Although it remains unclear whether Cyp26c1 deficiency
affects fertility (Uehara et al., 2007), Cyp26b1 regulated by
FGF2might play an important role in regulating RA actions
in the germline niche (Figures 4A and 4B). In this regard,
Garcia et al. (2014) reported that germ cell-derived NOTCH
signaling is required for proper spermatogenesis, which
regulates Cyp26b1 and Gdnf in Sertoli cells. They proposed
a model in which the population size of germ cells express-
ing NOTCH ligands affects the functions of Sertoli cells ex-
pressing Gdnf and Cyp26b1. It is intriguing how germ cells
themselves regulate their differentiation dynamics via
FGF2 and NOTCH pathways. Additionally, it is well known
that RA is the master regulator of the seminiferous epithe-
lial cycle (Hogarth et al., 2013). The RA concentration in
testes is determined by the balance between RA production
and metabolism (Hogarth et al., 2011). Furthermore, the
length of the seminiferous epithelial cycle varies depend-
ing on the animal species and is determined by the germ
cell genotype (Franc¸a et al., 1998; Sugimoto et al., 2012).
Therefore, it is also intriguing to speculate that germ cell-
derived FGF2/NOTCH signals might define the length of
the seminiferous epithelial cycle by regulating RA actions
in the germline niche.
Our results can explain the functional differences
between FGF2 and GDNF. In fact, FGF2 possesses a
molecular function that permits RA-mediated differentia-
tion by inducing differentiation-prone GFRA1+RARG+
spermatogonia. FGF2 also acts on the germline niche to
facilitate RA actions for spermatogonial differentiation (Fig-
ure 4A). Previous reports suggest cyclical fluctuation of
GDNF and RA in testicular tubules throughout the semi-
niferous epithelial cycle under physiological conditions
(Grasso et al., 2012; Hogarth et al., 2015b). Furthermore,
germ cell-deficient conditions are reported to be appropriate
for proliferation of undifferentiated spermatogonia rather
than spermatogonial differentiation (Nagano et al., 1999;
Nagai et al., 2012). Indeed, busulfan treatment upregulates
Gdnf expression in the testis (Figure S1) (Zohni et al.,
2012). These findings suggest the existence of GDNF- and
FGF2-dominant niches. The former is considered to pro-
mote the proliferation of undifferentiated spermatogonia
including SSCs (Figure 4C). Previous reports have demon-
strated that transplanted SSCs appear to focus on expansion
of their population without production of differentiating
progeny in the germ cell-depleted recipient testis (Nagano
et al., 1999; Nagai et al., 2012). Our present study also
showed a change in the Gdnf/Fgf2 balance in the germline
niche after germ cell depletion by busulfan (Figures S1D
and S1E). Considering the phenotype of Gdnf-transgenic
mice and GDNF-BGM-treated testes, a GDNF-dominant
niche might not permit spermatogonial differentiation. In
contrast, an FGF2-dominant niche is considered to permit
production of GFRA1+RARG+ spermatogonia for spermato-
genesis (Figure 4B). However, FGF2 signals are not sufficient,
and GDNF signals are indispensable for SSC maintenance
(Meng et al., 2000). Although FGF2 expression dynamics
remain to be elucidated in seminiferous tubules, it is
intriguing to speculate that the physiological germline
niche shifts cyclically between FGF2- and GDNF-dominant
states. For a complete overview of spermatogonial dynamics
in the germline niche, it is indispensable to understand
spatiotemporal regulation of FGF2 as well as GDNF and RA.
EXPERIMENTAL PROCEDURES
The institutional animal care and use committee of Shinshu
University (approval nos. 260013 and 280120) and Tokushima
University (experimental number 14,108) approved all animal
experimentation protocols. Human testis tissues without patho-
logical lesions were obtained and subjected to the experiments in
accordance with the institutional ethics review board of Shinshu
University to use human-derived material (test no. 3039), and
the institutional ethics review board of Nagano Red Cross Hospital
to use human-derived material (Nagano-Byo-Ki approval no. 25).
Written consent was obtained following the committee-approved
protocol before tissue collection.
Growth Factor Adsorption of BGMs
BGMs were prepared according to the original report (Tabata et al.,
1999). For single testis treatment, freeze-dried BGMs (1 mg) were
reconstituted with 10 mL of 1 mg/mL recombinant murine
FGF2 or GDNF (PeproTech, London, UK) in distilled-deionized-
autoclaved water. In this manner, growth factor solutions were
completely absorbed in BGMs, demonstrating that the growth fac-
tors were entirely contained within BGMs. After overnight adsorp-
tion of growth factors at 4C, the resultant BGMs were suspended
in 15 mL of autoclaved physiological saline for transplantation.
Statistical Analyses
Results are presented as means ± SEM. Significance of differences
betweenmeans for single comparisons was determined by the Stu-
dent’s t test. Multiple comparison analyses were carried out using
one-way ANOVA followed by Tukey’s honest significant difference
test. p < 0.05 was considered statistically significant.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental
Procedures, four figures, and two tables and can be found with
this article online athttps://doi.org/10.1016/j.stemcr.2018.03.016.
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